Skip to main content

8 Result(s)

within J Walewski Remove this filter English Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells

    This study investigated the development of peripheral blood natural killer (NK) and lymphokineactivated killer (LAK) cell activity in vivo in cancer patients treated with high doses of recombinant interleukin-...

    J. Walewski, E. Paietta, J. Dutcher… in Journal of Cancer Research and Clinical On… (1989)

  2. No Access

    Article

    CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma

    Patients with recurrent or refractory Hodgkin's and non-Hodgkin's lymphoma are increasingly being treated with high-dose therapy and hematopoietic cell transplantation. As minimal disease status at the time of...

    J Walewski, JB Krzyżanowska, E Kraszewska, E Lampka… in Medical Oncology (2000)

  3. No Access

    Article

    Rituximab (Mabthera™, rituxan™) in patients with recurrent indolent lymphoma

    The objective of this multiinstitutional study was to evaluate the safety and efficacy of rituximab at standard four weekly doses in patients with recurrent indolent lymphoma. Thirty-eight patients entered int...

    J. Walewski, E. Kraszewska, O. Mioduszewska, J. Romejko-Jarosińska… in Medical Oncology (2001)

  4. No Access

    Article

    High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group

    We analysed the treatment outcome of primary refractory HD patients managed with high-dose chemotherapy and haematopoietic cell transplantation. Data of 65 adult patients who underwent HDC/ASCT in nine Polish ...

    J Czyż, A Hellmann, R Dziadziuszko, J Hansz, J Goździk… in Bone Marrow Transplantation (2002)

  5. No Access

    Article

    Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy

    Our previously published study showed promising results of autologous stem cell transplantation (ASCT) in patients with primary resistant Hodgkin's disease (HD). Probabilities of overall survival (OS) and prog...

    J Czyz, R Szydlo, W Knopinska-Posluszny, A Hellmann… in Bone Marrow Transplantation (2004)

  6. No Access

    Article

    The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant

    In this multicenter study, we assessed the use of palifermin (recombinant human–keratinocyte growth factor 1) in the prevention of oral mucositis (OM) and acute GvHD (aGvHD) induced by a hematopoietic stem cel...

    B Nasilowska-Adamska, P Rzepecki, J Manko, A Czyz… in Bone Marrow Transplantation (2007)

  7. No Access

    Article

    Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma

    Follicular Lymphoma International Prognostic Index—FLIPI is an established clinical predictor for outcome in follicular lymphoma. The role of molecular abnormalities in blood and bone marrow of follicular lymp...

    E. Paszkiewicz-Kozik, J. Kulik, A. Fabisiewicz, A. Tysarowski… in Medical Oncology (2009)

  8. No Access

    Article

    Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials

    E Hoster, C H Geisler, J Doorduijn, B van der Holt, J Walewski, J Bloehdorn… in Leukemia (2016)